398 related articles for article (PubMed ID: 9699868)
1. Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cells.
Turgeon C; Gingras S; Carrière MC; Blais Y; Labrie F; Simard J
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):151-62. PubMed ID: 9699868
[TBL] [Abstract][Full Text] [Related]
2. Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.
Gingras S; Moriggl R; Groner B; Simard J
Mol Endocrinol; 1999 Jan; 13(1):66-81. PubMed ID: 9892013
[TBL] [Abstract][Full Text] [Related]
3. Crucial role of cytokines in sex steroid formation in normal and tumoral tissues.
Simard J; Gingras S
Mol Cell Endocrinol; 2001 Jan; 171(1-2):25-40. PubMed ID: 11165008
[TBL] [Abstract][Full Text] [Related]
4. Characterization and modulation of sex steroid metabolizing activity in normal human keratinocytes in primary culture and HaCaT cells.
Gingras S; Turgeon C; Brochu N; Soucy P; Labrie F; Simard J
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):167-79. PubMed ID: 14672737
[TBL] [Abstract][Full Text] [Related]
5. Induction of 3beta-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines.
Gingras S; Simard J
Endocrinology; 1999 Oct; 140(10):4573-84. PubMed ID: 10499513
[TBL] [Abstract][Full Text] [Related]
6. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues.
Labrie F; Simard J; Luu-The V; Bélanger A; Pelletier G
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):805-26. PubMed ID: 22217825
[TBL] [Abstract][Full Text] [Related]
7. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S; Côté S; Simard J
Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
[TBL] [Abstract][Full Text] [Related]
8. Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry.
El-Alfy M; Luu-The V; Huang XF; Berger L; Labrie F; Pelletier G
Endocrinology; 1999 Mar; 140(3):1481-91. PubMed ID: 10067877
[TBL] [Abstract][Full Text] [Related]
9. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
[TBL] [Abstract][Full Text] [Related]
10. Multiple signal transduction pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/Delta5-Delta4 isomerase in normal and tumoral target tissues.
Gingras S; Côté S; Simard J
J Steroid Biochem Mol Biol; 2001; 76(1-5):213-25. PubMed ID: 11384880
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
Couture P; Thériault C; Simard J; Labrie F
Endocrinology; 1993 Jan; 132(1):179-85. PubMed ID: 8380373
[TBL] [Abstract][Full Text] [Related]
12. Immunoelectron microscopic localization of 3beta-hydroxysteroid dehydrogenase and type 5 17beta-hydroxysteroid dehydrogenase in the human prostate and mammary gland.
Pelletier G; Luu-The V; El-Alfy M; Li S; Labrie F
J Mol Endocrinol; 2001 Feb; 26(1):11-9. PubMed ID: 11174850
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells.
Blais Y; Gingras S; Haagensen DE; Labrie F; Simard J
Mol Cell Endocrinol; 1996 Jul; 121(1):11-8. PubMed ID: 8865161
[TBL] [Abstract][Full Text] [Related]
14. Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause.
Liu ZJ; Lee WJ; Zhu BT
Cancer Res; 2005 Jul; 65(13):5802-11. PubMed ID: 15994956
[TBL] [Abstract][Full Text] [Related]
15. Multiple steroid metabolic pathways in ZR-75-1 human breast cancer cells.
Thériault C; Labrie F
J Steroid Biochem Mol Biol; 1991 Feb; 38(2):155-64. PubMed ID: 2004038
[TBL] [Abstract][Full Text] [Related]
16. TGFβ1 alters androgenic metabolites and hydroxysteroid dehydrogenase enzyme expression in human prostate reactive stromal primary cells: Is steroid metabolism altered by prostate reactive stromal microenvironment?
Piao YS; Wiesenfeld P; Sprando R; Arnold JT
J Steroid Biochem Mol Biol; 2013 Nov; 138():206-13. PubMed ID: 23770322
[TBL] [Abstract][Full Text] [Related]
17. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.
Penning TM; Burczynski ME; Jez JM; Hung CF; Lin HK; Ma H; Moore M; Palackal N; Ratnam K
Biochem J; 2000 Oct; 351(Pt 1):67-77. PubMed ID: 10998348
[TBL] [Abstract][Full Text] [Related]
18. Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.
Laplante Y; Rancourt C; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):146-53. PubMed ID: 18812208
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain.
Steckelbroeck S; Watzka M; Reissinger A; Wegener-Toper P; Bidlingmaier F; Bliesener N; Hans VH; Clusmann H; Ludwig M; Siekmann L; Klingmüller D
J Steroid Biochem Mol Biol; 2003 Jul; 86(1):79-92. PubMed ID: 12943747
[TBL] [Abstract][Full Text] [Related]
20. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
